Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC

Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC

BackgroundHead and neck squamous cell carcinoma (HNSCC), the most common head and neck cancer, is highly aggressive and heterogeneous, resulting in variable prognoses and immunotherapeutic outcomes. Natural killer (NK) cells play essential roles in malignancies’ development, diagnosis, and prognosis...

Full description

Bibliographic Details
Main Authors:	Hao Chi, Xixi Xie, Yingjie Yan, Gaoge Peng, Dorothee Franziska Strohmer, Guichuan Lai, Songyun Zhao, Zhijia Xia, Gang Tian
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Immunology
Subjects:	natural killer cell HNSCC tumor microenvironment immunotherapy prognostic signature
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1018685/full

Similar Items

Deciphering a Prognostic Signature Based on Soluble Mediators Defines the Immune Landscape and Predicts Prognosis in HNSCC
by: Hao Chi, et al.
Published: (2024-03-01)

Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity
by: Hao Chi, et al.
Published: (2023-03-01)

A novel natural killer-related signature to effectively predict prognosis in hepatocellular carcinoma
by: Deyang Xi, et al.
Published: (2023-09-01)

Cuprotosis Programmed-Cell-Death-Related lncRNA Signature Predicts Prognosis and Immune Landscape in PAAD Patients
by: Hao Chi, et al.
Published: (2022-10-01)

A signature based on circadian rhythm-associated genes for the evaluation of prognosis and the tumour microenvironment in HNSCC
by: Changqian Wang, et al.
Published: (2024-03-01)

Identification and validation of neurotrophic factor-related genes signature in HNSCC to predict survival and immune landscapes
by: Gaoge Peng, et al.
Published: (2022-11-01)

TRIM24 Expression as an Independent Biomarker for Prognosis and Tumor Recurrence in HNSCC
by: Luise Klapper, et al.
Published: (2022-06-01)

A Bioinformatics-Based Analysis of an Anoikis-Related Gene Signature Predicts the Prognosis of Patients with Low-Grade Gliomas
by: Songyun Zhao, et al.
Published: (2022-10-01)

Identification and validation of a novel tumor driver gene signature for diagnosis and prognosis of head and neck squamous cell carcinoma
by: Shixian Liu, et al.
Published: (2022-10-01)

A novel hypoxia-associated gene signature for prognosis prediction in head and neck squamous cell carcinoma
by: Jingyi Luo, et al.
Published: (2023-11-01)

Identification of a novel anoikis‐related gene signature to predict prognosis and tumor microenvironment in lung adenocarcinoma
by: Xiayao Diao, et al.
Published: (2023-01-01)

An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma
by: Xueyuan Huang, et al.
Published: (2023-01-01)

A lactate metabolism-related signature predicting patient prognosis and immune microenvironment in ovarian cancer
by: Linhua Zhu, et al.
Published: (2024-03-01)

The cuproptosis-related signature predicts prognosis and indicates immune microenvironment in breast cancer
by: Jia Li, et al.
Published: (2022-09-01)

A Novel pyroptosis-related signature for predicting prognosis and evaluating tumor immune microenvironment in ovarian cancer
by: Jiani Yang, et al.
Published: (2023-09-01)

A Newly Established Cuproptosis-Related Gene Signature for Predicting Prognosis and Immune Infiltration in Uveal Melanoma
by: Wei Huang, et al.
Published: (2023-07-01)

Inflammation-Related LncRNAs Signature for Prognosis and Immune Response Evaluation in Uterine Corpus Endometrial Carcinoma
by: Hongmei Gu, et al.
Published: (2022-06-01)

Analysis and identification of the necroptosis landscape on therapy and prognosis in bladder cancer
by: Zihan Zhao, et al.
Published: (2022-09-01)

Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma
by: Huihan Yu, et al.
Published: (2022-08-01)

An angiogenesis-related three-long non-coding ribonucleic acid signature predicts the immune landscape and prognosis in hepatocellular carcinoma
by: Wenjuan Wang, et al.
Published: (2023-03-01)

Integrating iron metabolism-related gene signature to evaluate prognosis and immune infiltration in nasopharyngeal carcinoma
by: Jiaming Su, et al.
Published: (2024-04-01)

An immune infiltration-related long non-coding RNAs signature predicts prognosis for hepatocellular carcinoma
by: Gen Li, et al.
Published: (2022-12-01)

Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer
by: Mingxuan Zhou, et al.
Published: (2022-10-01)

Impaired intratumoral natural killer cell function in head and neck carcinoma
by: Dalila Mele, et al.
Published: (2022-10-01)

A novel autophagy-related gene signature associated with prognosis and immune microenvironment in ovarian cancer
by: Jiani Yang, et al.
Published: (2023-04-01)

A novel glycolysis-related gene signature for predicting the prognosis of multiple myeloma
by: Bingxin Zhang, et al.
Published: (2023-06-01)

Developing a pyroptosis-related gene signature to better predict the prognosis and immune status of patients with head and neck squamous cell carcinoma
by: Dan Liu, et al.
Published: (2023-01-01)

Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma
by: Kefan Lin, et al.
Published: (2023-04-01)

Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma
by: Xingyu Peng, et al.
Published: (2022-09-01)

A risk signature based on necroptotic-process-related genes predicts prognosis and immune therapy response in kidney cell carcinoma
by: Jingxian Li, et al.
Published: (2022-09-01)

Analysis of myosin genes in HNSCC and identify MYL1 as a specific poor prognostic biomarker, promotes tumor metastasis and correlates with tumor immune infiltration in HNSCC
by: Ce Li, et al.
Published: (2023-09-01)

Leveraging a disulfidptosis‑related lncRNAs signature for predicting the prognosis and immunotherapy of glioma
by: Di Chen, et al.
Published: (2023-12-01)

Immune Landscape and Classification in Lung Adenocarcinoma Based on a Novel Cell Cycle Checkpoints Related Signature for Predicting Prognosis and Therapeutic Response
by: Jian Yang, et al.
Published: (2022-05-01)

A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer
by: Weizhuo Wang, et al.
Published: (2023-08-01)

Identifying a novel cuproptosis-related necroptosis gene subtype-related signature for predicting the prognosis, tumor microenvironment, and immunotherapy of hepatocellular carcinoma
by: Yuanxin Shi, et al.
Published: (2023-05-01)

Exploration of prognosis and immunometabolism landscapes in ER+ breast cancer based on a novel lipid metabolism-related signature
by: Lesang Shen, et al.
Published: (2023-07-01)

Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma
by: Weidong Chen, et al.
Published: (2024-01-01)

Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma
by: Yuan Qin, et al.
Published: (2022-09-01)

Anoikis-related signature predicts prognosis and characterizes immune landscape of ovarian cancer
by: Jiani Yang, et al.
Published: (2024-02-01)

Construction of m6A-based prognosis signature and prediction for immune and anti-angiogenic response
by: Xiang-Xu Wang, et al.
Published: (2022-10-01)